Experimental cancer drug trial halted early

NCT ID NCT05229601

Terminated Disease control Sponsor: HiFiBiO Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new drug called HFB301001 in 31 adults with advanced solid tumors (like sarcoma, kidney cancer, or melanoma) that had not responded to prior treatments. The main goal was to check the drug's safety and find the best dose. The study was terminated, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma hepatocellular carcinoma melanoma renal cell carcinoma sarcoma soft tissue sarcoma Squamous Cell Carcinoma of Head and Neck uterine carcinosarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK SQUAMOUS CELL CARCINOMA HEPATOCELLULAR CARCINOMA MELANOMA RENAL CELL CARCINOMA SOFT TISSUE SARCOMA UTERINE CARCINOSARCOMA

Contacts and locations

Locations

Dana Farber Cancer Institute

Boston, Massachusetts, 02215, United States
Hospital Clinico Universitario de Valencia

Valencia, 46010, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital Universitario Vall d'Hebron

Barcelona, 08035, Spain
Mayo Clinic

Scottsdale, Arizona, 85259, United States
Mayo Clinic

Jacksonville, Florida, 32224, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
NEXT Virginia Cancer Specialists

Fairfax, Virginia, 22031, United States
USC/Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States
University of Maryland

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.